230 related articles for article (PubMed ID: 6685512)
1. Efficacy of isosorbide dinitrate tape on exercise tolerance of patients with angina pectoris.
Saito M; Nobuyoshi M; Nakamura N; Nishiyama S; Haze K; Hiramori K; Ikeda M
Arzneimittelforschung; 1983; 33(9):1301-5. PubMed ID: 6685512
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of antianginal efficacy of long-term therapy with low dose isosorbide dinitrate in patients with stable angina pectoris].
Kośmicki M; Sadowski Z
Przegl Lek; 2000; 57(9):455-8. PubMed ID: 11199864
[TBL] [Abstract][Full Text] [Related]
3. [Hemodynamic and anti-angina effects of transdermal nitroglycerin after acute and chronic administration. Additive effect of sublingual isosorbide dinitrate].
Scardi S; Pandullo C; Pivotti F; Ceschia G; Pollavini G
G Ital Cardiol; 1986 Nov; 16(11):895-903. PubMed ID: 3104123
[TBL] [Abstract][Full Text] [Related]
4. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
Kośmicki M; Szwed H; Kowalik I; Sadowski Z
Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
[TBL] [Abstract][Full Text] [Related]
5. [Long-term therapy of stress angina pectoris by a single daily administration of 120 mg isosorbide dinitrate in retard form. Comparison of monotherapy and combination therapy with atenolol and nifedipine].
Blasini R; Brügmann U; Reiniger G; Rudolph W
Herz; 1985 Jun; 10(3):163-71. PubMed ID: 3926613
[TBL] [Abstract][Full Text] [Related]
6. [Dose-effect relationship of isosorbide dinitrate in the treatment of angina pectoris (author's transl)].
Schneider W; Stahl B; Kaltenbach M; Bussmann WD
Dtsch Med Wochenschr; 1982 May; 107(20):771-6. PubMed ID: 7075499
[TBL] [Abstract][Full Text] [Related]
7. Effect of intervals between doses on the development of tolerance to isosorbide dinitrate.
Parker JO; Farrell B; Lahey KA; Moe G
N Engl J Med; 1987 Jun; 316(23):1440-4. PubMed ID: 3574424
[TBL] [Abstract][Full Text] [Related]
8. [Comparative evaluation of antianginal efficacy of isosorbide dinitrate in various doses in patients with stable angina].
Kośmicki M; Sadowski Z
Wiad Lek; 2000; 53(7-8):388-93. PubMed ID: 11070759
[TBL] [Abstract][Full Text] [Related]
9. [Tolerance to a sustained release form of isosorbide dinitrate: comparison between 20 mg four times and 40 mg twice-daily administrations].
Hiasa Y; Hamai K; Wada T; Ootani R; Shinohara H; Aihara T; Bando M; Nakai Y; Kataoka Y
Kokyu To Junkan; 1991 Sep; 39(9):925-30. PubMed ID: 1749871
[TBL] [Abstract][Full Text] [Related]
10. Chronic treatment and tolerance with high doses of isosorbide dinitrate in a slow release form in patients with angina pectoris.
Becker HJ; Fach WA; Weil J; Hüwer HD
Z Kardiol; 1983; 72 Suppl 3():199-202. PubMed ID: 6666222
[TBL] [Abstract][Full Text] [Related]
11. [Extent of therapeutic effect and duration of 1 capsule of 120 mg isosorbide dinitrate in a slow release form].
Vogler AC; Silber S; Spiegelsberger F; Theisen K
Z Kardiol; 1989 Jul; 78(7):421-6. PubMed ID: 2672652
[TBL] [Abstract][Full Text] [Related]
12. Sustained antianginal efficacy of oral high-dose isosorbide dinitrate in patients with coronary heart disease.
Schneider W; Wietschoreck A; Bussmann WD; Kaltenbach M
Z Kardiol; 1983; 72 Suppl 3():259-67. PubMed ID: 6666231
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of eccentric dosing with sustained-release isosorbide dinitrate in patients with angina pectoris.
Parker JO; Baird MG
Can J Cardiol; 1994 Nov; 10(9):909-12. PubMed ID: 7954026
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of nifedipine, verapamil, isosorbide dinitrate and propranolol on exercise-induced angina pectoris.
de Ponti C; Mauri F; Ciliberto GR; Carù B
Eur J Cardiol; 1979 Jul; 10(1):47-58. PubMed ID: 467482
[TBL] [Abstract][Full Text] [Related]
15. Effect of a combination of pindolol and isosorbide dinitrate on ischemic ST-segment depression and exercise ability in angina pectoris.
Dorow P; Schiess W
Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):419-22. PubMed ID: 6386704
[TBL] [Abstract][Full Text] [Related]
16. [Hemodynamic effects of a transdermal formulation of isosorbide dinitrate and its pharmacokinetics in conscious dogs].
Kogi K; Tanaka O; Kimura T; Saito T
Nihon Yakurigaku Zasshi; 1982 Oct; 80(4):279-88. PubMed ID: 7152395
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic measurements and exercise testing to assess the development of tolerance against slow-release isosorbide dinitrate.
Weidemann H; Schuon J; Schober B
Z Kardiol; 1983; 72 Suppl 3():229-32. PubMed ID: 6666226
[TBL] [Abstract][Full Text] [Related]
18. [New drug forms of isosorbide dinitrate: the problem of an objective evaluation in patients with ischemic heart disease].
Martsevich SIu; Metelitsa VI; Kozyreva MP; Blagodatskikh SV; Simkhaev LS; Piotrovskiĭ VK
Farmakol Toksikol; 1991; 54(3):53-6. PubMed ID: 1915825
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation using serial exercise tests of verapamil alone and combined with isosorbide dinitrate in exertional angina].
Vázquez de Prada JA; Ruano J; Zueco J; Colman T; González-Vílchez F; Pajarón A
Rev Esp Cardiol; 1989 Oct; 42(8):513-8. PubMed ID: 2602607
[TBL] [Abstract][Full Text] [Related]
20. The development and reversal of tolerance to antianginal effect of isosorbide dinitrate in patients with effort angina.
Toyosaki N; Katsuki T; Fujii M; Kawada Y; Komaba A; Watabiki H; Hasegawa H; Suzuki S; Natsume T; Yaginuma T
Jpn Circ J; 1989 May; 53(5):395-405. PubMed ID: 2769927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]